Remibrutinib
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
Bruton's tyrosine kinase inhibition for food-induced anaphylaxis.
Journal: Current opinion in allergy and clinical immunology
Published: August 22, 2026
Emerging pharmacotherapies for chronic spontaneous urticaria: spotlight on BTK inhibitors.
Journal: Expert opinion on pharmacotherapy
Published: August 19, 2026
Expanding the Therapeutic Horizon for Chronic Spontaneous Urticaria - Finally.
Journal: Journal of the American Academy of Dermatology
Published: July 20, 2026
Emerging synthetic drugs for the management of hidradenitis suppurativa: a comprehensive update.
Journal: Expert opinion on pharmacotherapy
Published: June 24, 2026
Emerging and Newly Approved Therapies for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Narrative Review.
Journal: Diseases (Basel, Switzerland)
Published: June 24, 2026
Remibrutinib in inadequately controlled cholinergic urticaria: a real-world case series.
Journal: Journal of the American Academy of Dermatology
Published: June 17, 2026
Treatment of mast cell-mediated angioedema
Journal: Dermatologie (Heidelberg, Germany)
Published: June 01, 2026
A New Drug Target in Allergic Diseases: Bruton Tyrosine Kinase.
Journal: Journal of investigational allergology & clinical immunology
Published: April 27, 2026
Approach to Urticaria and Angioedema in the Older Patient.
Journal: The journal of allergy and clinical immunology. In practice
Published: April 09, 2026
Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions.
Journal: Journal of drugs in dermatology : JDD
Published: April 03, 2026
Remibrutinib (Rhapsido) for chronic spontaneous urticaria.
Journal: Trends in pharmacological sciences
Published: April 03, 2026
Bruton protein-tyrosine kinase (BTK) FDA-approved small molecule inhibitors used for the management of neoplastic and inflammatory disorders.
Journal: Pharmacological research
Published: March 31, 2026
Last Updated: 09/26/2026